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Vibrio cholerae serogroup O1, the causative agent of the diarrheal disease cholera, is divided into two
biotypes: classical and El Tor. Both biotypes produce the major virulence factors toxin-coregulated pilus (TCP)
and cholera toxin (CT). Although possessing genotypic and phenotypic differences, El Tor biotype strains
displaying classical biotype traits have been reported and subsequently were dubbed El Tor variants. Of
particular interest are reports of El Tor variants that produce various levels of CT, including levels typical of
classical biotype strains. Here, we report the characterization of 10 clinical isolates from the International
Centre for Diarrhoeal Disease Research, Bangladesh, and a representative strain from the 2010 Haiti cholera
outbreak. We observed that all 11 strains produced increased CT (2- to 10-fold) compared to that of wild-type
El Tor strains under in vitro inducing conditions, but they possessed various TcpA and ToxT expression
profiles. Particularly, El Tor variant MQ1795, which produced the highest level of CT and very high levels of
TcpA and ToxT, demonstrated hypervirulence compared to the virulence of El Tor wild-type strains in the
infant mouse cholera model. Additional genotypic and phenotypic tests were conducted to characterize the
variants, including an assessment of biotype-distinguishing characteristics. Notably, the sequencing of ctxB in
some El Tor variants revealed two copies of classical ctxB, one per chromosome, contrary to previous reports
that located ctxAB only on the large chromosome of El Tor biotype strains.
demics, the first six of which were caused by the classical O1
biotype. The current (seventh) pandemic, which began in 1961,
is the result of the El Tor O1 biotype, which has essentially
displaced the classical biotype globally since 1993 (5, 32, 42).
Although the El Tor biotype was first isolated in 1937 and its
pandemic potential debuted 24 years later in 1961, both biotypes coexisted until 1992 (32). During this time, the El Tor
biotype was responsible for most outbreaks; however, the classical biotype still was responsible for isolated incidents until
1992. These incidents included a large outbreak in west Pakistan in 1968 and the appearance of the classical biotype in
Bangladesh in 1979, with a continuous presence until the end
of 1992 (5). However, since 2001, a series of reports have been
published revealing clinical isolates, from as far back as the
early 1990s, that are of El Tor biotype background but possess
some classical biotype traits (3, 4, 28, 34, 35, 36, 43). For
example, the ctxA gene, which is the first gene of the ctx phage
operon and codes for the A subunit of the cholera toxin, is
completely conserved in sequence between the two O1 biotypes. However, ctxB, which is the second gene in the operon
and codes for the B subunit of the cholera toxin, is identical in
sequence between the biotypes except for two bases, a key
difference used to distinguish the biotypes. The bases at positions 115 and 203 are cytosines in the classical O1 biotype,
whereas in El Tor O1 biotypes they both are thymines. These
base transitions, which result in amino acid conversions of
H39Y and T68I, respectively, are completely conserved within
each biotype, allowing them to be used as reliable markers for
biotype characterization. These clinical El Tor O1 strains were

Vibrio cholerae is a Gram-negative, curved-rod-shaped bacterium that is the causative agent of the watery diarrheal disease cholera. The structure of the cell surface lipopolysaccharide O antigen is used to classify V. cholerae into more than 200
serogroups, of which only two, O1 and O139, possess the potential to cause epidemic or pandemic cholera. The O1 serogroup is further divided into two biotypes, classical and El Tor,
which evolved from independent lineages (20, 22), and they
display genotypic and phenotypic differences.
V. cholerae O1 is distinguished by two of its major virulence
factors, cholera toxin (CT) and the toxin-coregulated pilus
(TCP). The cholera toxin is encoded by ctxA and ctxB, which
are found on the CTX prophage (49), and is responsible for
the manifestation of diarrheal disease with severe water and
electrolyte loss. The TCP, encoded by the tcp operon in the
Vibrio pathogenicity island (VPI), is required for V. cholerae
colonization of the small intestinal epithelium (17, 21, 24, 47).
Although these essential virulence factors are regulated primarily by ToxT via the ToxR virulence regulon (in conjunction
with AphA and AphB) (26, 27) in both classical and El Tor
biotypes, the genes are differentially expressed between the
biotypes, particularly under in vitro inducing conditions.
Since 1817, the world has experienced seven cholera pan-
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found to contain the classical biotype cholera toxin B subunit
gene (ctxB) and have since been termed El Tor variants (34,
39). These El Tor variants have become a major focus of
research, since other El Tor variants also have been identified
in Asia and Mozambique (29, 34, 35, 38) and recently have
been a focus of attention in Haiti (1, 6, 7, 8, 9). Of particular
concern are the recently published results indicating that some
of the clinically isolated El Tor variants produce different levels of cholera toxin, including some isolates that produce
higher levels than classical biotype strains (16).
Although evidence has been presented demonstrating that
the El Tor biotype has globally displaced the classical biotype
(19, 42), the emergence of El Tor variants has warranted the
use of standard genotypic and phenotypic assays to determine
the biotype background of new isolates. Standard phenotypic
assays, including polymyxin B resistance, hemolysis assays,
phage sensitivities, and the Voges-Proskauer tests, are frequently employed in some combination (4, 11, 45). Genetic
markers, such as the ctxB gene, have been used to distinguish
the cholera toxin between classical and El Tor biotypes (11, 33,
35) to classify isolates as El Tor variants. The sequences of
tcpA, which codes for the pilin subunits of the TcpA apparatus,
and rstR, the repressor found in the RS1 element, which codes
for the regulatory region for phage replication, also have been
used in determining the biotypes of new isolates (4, 11, 39, 45).
El Tor variants were first identified from sporadic strains of
V. cholerae O1 isolated from Matlab Hospital in Bangladesh
(37), and their importance was accentuated with similar El Tor
variants identified from a 2004 epidemic in Mozambique (3).
Here, we present the characterization of 10 Matlab variant
clinical strains (Bgd1, Bgd2, Bgd3, Bgd4, Bgd5, Bgd6, Bgd7,
Bgd8, MQ1795, and MQ04) isolated from patients at Matlab
Hospital and the recently isolated El Tor variant (BAA-2163),
which was identified as the causative agent of the 2010 cholera
outbreak in Haiti. We report the results of various genotypic
and phenotypic assays used to determine the biotype background for each strain. However, more importantly, we report
relative cholera toxin production levels expressed by all variants, the expression levels of the virulence factors TcpA and
ToxT, and quantitative data for biofilm production and other
phenotypic traits, and we compare these data to those for
classical O395, El Tor C6706, and El Tor N16961 wild-type
strains. Finally, in agreement with the virulence factor production profiles, we demonstrate the virulence profile of the high
producers of cholera toxin (Bgd8 and MQ1795), as well as
some of the genetically different representative variant strains
(Bgd2, Bgd3, MQ04, and BAA-2163), using the infant mouse
cholera model.
MATERIALS AND METHODS
Clinical patient profiles. The clinical profiles of the patients from Matlab
Hospital in Bangladesh and representative data for the patients from Haiti are
given in Table 1. All patients were hospitalized with clinical manifestations of
cholera and were treated accordingly.
Bacterial strains and general growth conditions. All strains used in this study
are listed in Table 2. The Matlab clinical isolates were previously identified as El
Tor variants as part of a collective pool of clinical isolates (37). The strain
BAA-2163, isolated in Haiti, also was identified as an El Tor variant (12). These
strains were grown simultaneously under the same conditions with wild-type
classical O395, wild-type El Tor strains C6706 and N16961, and classical
O395⌬tcpA or O395⌬toxT (for TcpA or ToxT production, respectively). Poly-
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TABLE 1. Patient profilesc

Strain

Patient
sex

Age (yr)

Dehydration
status

Acute
watery
diarrhea
status

Serotype

Bgd1
Bgd2
Bgd3
Bgd4
Bgd5
Bgd6
Bgd7
Bgd8
MQ1795
MQ04
BAA-2163a

F
F
M
F
F
F
F
M
M
NA
NA

17
7
19
13
35
5
13
15
90
4
NAb

Severe
Severe
Severe
Mild
Severe
Severe
Severe
Severe
None
None
NA

Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes

Ogawa
Ogawa
Inaba
Inaba
Inaba
Inaba
Ogawa
Ogawa
Inaba
Inaba
Ogawa

a
Haiti 2010 outbreak strain: NCBI strain 2010EL-1786 (accession number
AELH00000000).
b
This isolate was a representative strain of the outbreak in Haiti, where the
patient ages ranged from 0 to 84 years old.
c
F, female; M, male; NA, not available.

myxin B resistance was determined by patching strains on Luria-Bertani (LB)
medium plates containing polymyxin B (50 IU ml⫺1) (Sigma-Aldrich, St. Louis,
MO), and strain motility was determined by stabbing into 0.3% agar LB plates
and incubating at 37°C for 6 h, as previously described (25). Voges-Proskauer
medium (MR-VP) (Becton Dickinson, Sparks, MD) was inoculated with each
strain as described previously (25). Hemolytic properties were determined by
patching the different strains onto blood agar plates (Remel, Lenexa, KS) that
then were incubated overnight at 37°C and observed for the degree of hemolysis
indicated by clearing on the plate. The ability to use citrate as a sole carbon
source was determined by patching the individual strains onto minimal citrate
medium plates (48) and incubating them at 37°C overnight. The ability to hydrolyze casein also was determined by patching on milk agar plates followed by
incubation at 37°C. Classical biotype-inducing growth conditions were performed
in LB (starting pH 6.5) at 30°C with aeration for 15 h. El Tor biotype TCPinducing conditions were AKI-inducing conditions as previously described (18).
The biofilm assay was performed as previously described (40) on the El Tor
variant strains, wild-type classical O395, and wild-type El Tor C6706 and N16961.
Briefly, cultures were grown in AKI-inducing medium, without shaking, in 96well U-bottom plates (Becton Dickinson, Sparks, MD) overnight. The cultures
were removed and the plates washed, and then the biofilm formed on the sides
of the well was stained with 0.1% crystal violet. The crystal violet then was
dissolved with glacial acetic acid, and the amount of crystal violet (Bio-Rad,
Hercules, CA) was quantitated at the optical density of 550 nm (OD550).
Cholera toxin production assay. GM1 ganglioside enzyme-linked immunosorbent CT assays (15) were performed on the culture supernatants of the wild-type
classical, wild-type El Tor, and El Tor variant cultures grown under AKI-inducing conditions, and the total ng of CT produced per ml of culture per OD600 unit
(ng CT ml⫺1 OD600⫺1) was determined.
Immunoblot assays for ToxT and TcpA. Whole-cell extracts (WCE) were
prepared from all of the cultures grown under AKI-inducing conditions for 3.5
(for ToxT) or 7.5 h (for TcpA) at 37°C. AKI-inducing conditions involve incubation without aeration for the first 3.5 h, followed by aeration for the next 4 h.
WCE protein concentrations were determined, and either 10 (for ToxT) or 8 g
(for TcpA) of WCE was run on a 16% Tris-glycine polyacrylamide gel (Invitrogen, Carlsbad, CA), transferred to nitrocellulose, probed with anti-ToxT or
anti-TcpA, and visualized using the ECL (enhanced chemiluminescence) detection system (GE Healthcare, Little Chalfont, Buckinghamshire, United Kingdom).
Infant mouse cholera model. The El Tor variants were tested for virulence
alongside the two wild-type El Tor strains, C6706 and N16961, using suckling
CD-1 mice (n ⫽ 6) (Charles River Laboratories, Kingston, NY) as previously
described (23), with an infectious dose of ⬃7.5 ⫻ 108 bacteria.
PCR assay. Primers (Integrated DNA Technologies, Coralville, IA) used in
this study to amplify tcpA, ctxB, and the CTX phage/ancestral chromosome (large
and small) junction are listed in Table 3. Genomic DNA of all strains was
prepared using a DNA purification kit (Qiagen, Valencia, CA). For the amplification and sequencing of tcpA in all strains in this study, oligonucleotides
tcpA-For (primer 32) and tcp-Rev (primer 33) were used, and for ctxB the
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TABLE 2. Strains used in this studya
Strain

Relevant description

E. coli
S17-1pir
V. cholerae
O395
C6706
N16961
C6706⌬toxT
O395⌬toxT
O395⌬tcpA
MQ1795
MQ04
Bgd1
Bgd2
Bgd3
Bgd4
Bgd5
Bgd6
Bgd7
Bgd8
BAA-2163
a

O1 biotype

Reference or source

recA thi pro hsdR⫺ M⫹ 关RP4-2-Tc::Mu::Kmr Tn7兴 ( pir);
Tmpr Strr

NA

12

Wild-type Ogawa; Strr
Wild-type Inaba; Strr
Wild-type Inaba; Strr
C6706⌬toxT; Strr
O395⌬toxT; Strr
O395⌬tcpA; Strr
El Tor
El Tor
El Tor
El Tor
El Tor
El Tor
El Tor
El Tor
El Tor
El Tor
El Tor

Classical
El Tor
El Tor
El Tor
Classical
Classical
El Tor variant
El Tor variant
El Tor variant
El Tor variant
El Tor variant
El Tor variant
El Tor variant
El Tor variant
El Tor variant
El Tor variant
El Tor variant

This study; laboratory collection
This study; laboratory collection
This study; laboratory collection
This study; laboratory collection
This study; laboratory collection
23
34; Bangladesh
34; Bangladesh
This study; Bangladesh
This study; Bangladesh
This study; Bangladesh
This study; Bangladesh
This study; Bangladesh
This study; Bangladesh
This study; Bangladesh
This study; Bangladesh
This study; Haiti

NA, not applicable; Tmpr, trimethoprim resistant; Strr, streptomycin resistant.

oligonucleotides ctxAB-Rev (primer 39) and ctxB-For (primer 51) were used. For
chromosome-specific PCR, the oligonucleotides ctxAB1-Rev (primer 56) and
ctxAB2-Rev (primer 57) were used individually with oligonucleotide ctxB-For
(primer 51).
Phylogenetic analysis. Phylogenetic analysis was performed on the El Tor
variants against classical wild-type O395 and El Tor wild-type N16961 as previously described (2), using the neighbor-joining method and P distance to determine relatedness between the strains. Gene sequences for groEL (classical,
VC0395_A2237; El Tor, VC2664), gyrB (classical, VC0395_A2504; El Tor,
VC0015), pryC (classical, VC0313; El Tor, VCA0925), and recA (classical,
VC0395_A0070; El Tor, VC0543) were analyzed for each strain, and sequences
were compared using MEGA5 (46). For comparison, a non-O1 environmental V.
cholerae isolate, 12129, also was incorporated. Additional analyses were conducted comparing ctxB and tcpA sequences between the variants and both wildtype classical O395 and El Tor N16961.

RESULTS
Phenotypic profiles reveal a wide range of properties among
the clinical isolates with no unifying trend. (i) Polymyxin B
resistance, hemolysis, citrate metabolism, and casein hydrolysis profiles. Standard phenotypic assays were conducted to
comprehensively characterize the background of the El Tor
variant clinical isolates. All variants were able to grow on LB
medium supplemented with polymyxin B just as well as the
wild-type El Tor strains C6706 and N16961 (Table 4), whereas
the wild-type classical strain exhibited polymyxin B sensitivity.
When patched onto blood agar plates to determine hemolytic

TABLE 3. Primers used in this study
Primer
name

Sequence (5⬘–3⬘)

Primer
no.

tcpA-For
tcpB-Rev
ctxAB-Rev
ctxB-For
ctxAB1-Rev
ctxAB2-Rev

CCGCACCAGATCCACGTAGGTGGG
GTCGGTACATCACCTGCTGTGGGGCAG
CATCATCGAACCACAAAAAAGCTTACTGAGG
GGGAATGCTCCAAGATCATCGATGAGTAATAC
CGATGCCGCTCTAAAGCTGCTTGCCGCTGAACTC
CTCAAGCTGCGATCAGCATGGCGTGGTCAGACG

32
33
39
51
56
57

activity, the variants demonstrated a range of degrees of hemolytic abilities, ranging between the levels for wild-type
C6706 and N16961 (Table 4). Wild-type classical O395 did not
demonstrate any hemolysis. All of the clinical variants studied
also were able to use citrate as a sole carbon source and grew
just as well as wild-type El Tor C6706 and N16961 strains,
whereas wild-type classical O395 did not grow at all. Akin to
wild-type El Tor C6706 and unlike wild-type classical O395 and
wild-type El Tor N16961, all of the variants studied here were
able to hydrolyze the casein in the milk agar plates, resulting in
a clear zone around the inoculation patch.
(ii) All clinical variants studied demonstrated motility comparable to that of wild-type N16961. The motility of the variants at 37°C also was determined to help characterize their
phenotypic characteristics (Table 4). The motility plate assays
revealed that all variants studied exhibited motility characteristics similar to those of wild-type El Tor N16961. Motility was
measured as an average diameter of growth of three independent trials at 37°C and compared to the diameter of growth of
wild-type N16961.
(iii) VP assay results for acetoin production profiles are
akin to results for classical O395. The Voges-Proskauer (VP)
test was performed to determine whether or not the variants
produce acetoin as an end product of glycerol metabolism
(Table 4). El Tor biotype strains are known for producing a
very bright red color, indicating a positive VP result, whereas
classical biotype strains produce no color change, indicating a
negative VP result. Surprisingly, all clinical variants studied
tested negative or weakly positive (slight pink coloration) for
the VP reaction (Fig. 1).
(iv) Biofilm production levels varied among the clinical variants studied. The El Tor variant strains were tested for the
ability to produce biofilm, and their production levels were
compared to the levels of biofilm produced by both of the
wild-type El Tor strains as well as the wild-type classical O395
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TABLE 4. Summary of phenotypic traits of the El Tor variants compared to wild-type classical biotype strain O395 and wild-type El Tor
biotype strains C6706 and N16961a
Phenotype

O395

C6706

N16961

Bgd1

Bgd2

Bgd3

Bgd4

Bgd5

Bgd6

Bgd7

Bgd8

MQ1795

MQ04

BAA-2163

Polymyxin B resistance
Hemolysis
Voges-Proskauer
Citrate metabolism
Motility at 37°C
Casein hydrolysis
Biofilm production

⫺
⫺
⫺
⫺
⫹
⫺
⫹⫹

⫹
⫹
⫹⫹⫹
⫹
⫹⫹
⫹
⫹⫹⫹

⫹
⫹
⫹⫹⫹
⫹
⫹⫹⫹
⫺
⫹

⫹
⫹
⫹/⫺
⫹
⫹⫹⫹
⫹
⫹⫹

⫹
⫹
⫹/⫺
⫹
⫹⫹⫹
⫹
⫹

⫹
⫹
⫹/⫺
⫹
⫹⫹⫹
⫹
⫹

⫹
⫹
⫹/⫺
⫹
⫹⫹⫹
⫹
⫹

⫹
⫹
⫹/⫺
⫹
⫹⫹⫹
⫹
⫹

⫹
⫹
⫹/⫺
⫹
⫹⫹⫹
⫹
⫹

⫹
⫹
⫹/⫺
⫹
⫹⫹⫹
⫹
⫹

⫹
⫹
⫹/⫺
⫹
⫹⫹⫹
⫹
⫹

⫹
⫹
⫺
⫹
⫹⫹⫹
⫹
⫹

⫹
⫹
⫹/⫺
⫹
⫹⫹⫹
⫹
⫹⫹⫹

⫹
⫹
⫹/⫺
⫹
⫹⫹⫹
⫹
⫹

a

⫹, ⫹⫹, and ⫹⫹⫹, degree of positivity; ⫺, negative; ⫹/⫺, weakly positive.

strain (Table 4). Both initial visual observations of biofilm
production and quantitated amounts of dissolved crystal violet
(at OD550) indicated that all clinical variants studied here,
except Bgd1 and MQ04, produced levels of biofilm comparable
to that of wild-type El Tor N16961, which is much less than
that produced by either wild-type El Tor C6706 or wild-type
classical O395.
The El Tor variants produced more cholera toxin than wildtype El Tor under AKI-inducing conditions. Cell-free culture
supernatant of each strain was used to determine the amount
of cholera toxin produced under both classical and AKI-inducing conditions. As expected, under classical inducing conditions, only the classical wild-type O395 produced detectable
levels of cholera toxin (⬃7,000 ng CT ml⫺1 OD600⫺1; data not
shown). However, under AKI-inducing conditions (Fig. 2), the
El Tor variants produced larger amounts of cholera toxin than
all three wild-type strains, classical O395, El Tor C6706, and El
Tor N16961 (⬃2,420, ⬃470, and ⬃1,800 ng CT ml⫺1 OD600⫺1,
respectively). Bgd8 (⬃10,900 ng CT ml⫺1 OD600⫺1) and
MQ1795 (⬃12,500 ng CT ml⫺1 OD600⫺1) produced the largest
amounts of toxin, with average production of ⬃6- and ⬃7-fold
larger amounts than El Tor N16961. The other nine variants
also produced more cholera toxin than N16961, but in a
smaller range of ⬎2- to 5-fold.
In vitro ToxT and TcpA production profiles differ across the
El Tor variants. ToxT (32 kDa) is an AraC family transcriptional regulator which activates the expression of the tcp
operon in V. cholerae under virulence gene-inducing conditions. TcpA (20.5 kDa) is the major pilin protein of the TCP
apparatus and is an essential virulence factor in V. cholerae.
TcpA is encoded by the first gene in the tcp operon, tcpA,
which is activated by ToxT. After growing the El Tor variant
strains and the appropriate wild-type strains (classical O395

and El Tor C6706 and N16961) under AKI-inducing conditions, the levels of TcpA and ToxT proteins produced were
observed. As seen in Fig. 3A, variants MQ1795 and Bgd8
produced higher levels of TcpA than the wild-type El Tor
N16961. The other El Tor variants were observed to produce
TcpA levels that were less than that of N16961 and more
comparable to that of C6706. Interestingly, classical O395 produced TcpA at levels similar to those of wild-type El Tor
N16961 under AKI-inducing conditions.
However, a different pattern of protein production was observed in levels of ToxT across the strains (Fig. 3B). We observed that El Tor variants Bgd8, MQ1795, and MQ04 produced noticeably more ToxT than both wild-type El Tor C6706
and N16961, with levels comparable to that of classical O395.
The other eight variants produced levels of ToxT comparable
to that wild-type El Tor C6706, all of which were greater than
that of N16961. Wild-type classical O395 produced more ToxT
than wild-type El Tor C6706 and N16961 strains.
Variants Bgd8 and MQ1795 are hypervirulent in the infant
mouse cholera model compared to wild-type El Tor N16961
and C6706. The virulence of the El Tor variant strains was
determined relative to the virulence of the wild-type El Tor
strains C6706 and N16961 by infecting the infant mice (infectious dose of ⬃7.5 ⫻ 108 in this study) and observing the length
of time for half the infected infant mouse population (n ⫽ 6)
to succumb to the cholera infection (LT50) (Fig. 4). Of the 11
El Tor variant strains available, only certain representative
strains were used in the infant mouse cholera model based on
the different genotypes, particularly the number of predicted
copies of the ctxAB operon, the mutations found in tcpA, and
the heptad copy number (Table 5). The strains used in this
study include MQ1795, which produced the most CT and carries two copies of the ctxAB operon (Fig. 5C), all three tcpA

FIG. 1. Voges-Proskauer (VP) results for acetoin production by the El Tor variants. V. cholerae classical biotype strain O395 is negative for the
VP test. El Tor biotype strains C6706 and N16961 are bright pink, which is characteristic of a positive VP test result. The El Tor variants in this
study all show various degrees of no pink to slight pink color, which is interpreted as a negative or weakly positive VP result, respectively. For
comparison, VP-negative E. coli S17-1pir also is shown.
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FIG. 2. Enzyme-linked immunosorbent assay (ELISA) for total
cholera toxin production by El Tor variant strains. Total cholera toxin
(CT) produced by wild-type classical O395, wild-type El Tor C6706,
wild-type El Tor N16961, and the El Tor variants Bgd1, Bgd2, Bgd3,
Bgd4, Bgd5, Bgd6, Bgd7, Bgd8, MQ1795, MQ04, and BAA-2163 under
AKI-inducing conditions was determined by a colorimetric ELISA.
The CT assay was conducted in triplicate, and the mean CT produced
(ng CT ml⫺1 OD600⫺1) is shown with standard deviations for each
strain. A two-tailed standard t test yielded P values of ⬍0.05 when the
El Tor variants were compared to wild-type El Tor C6706 (ⴱ) and
wild-type El Tor N16961 (ⴱⴱ).

mutations, and four heptad repeats (TTTTGAT), which serve
as binding sites for the activators ToxR (30, 31, 41) and ToxT
(10, 50); MQ04, which contains two potential copies of ctxAB
(Fig. 5C) but produced elevated levels of ToxT and wild-type
N16961 levels of TcpA (Fig. 3), contains all three tcpA mutations and four heptad repeats; Bgd2 contains two potential
copies of ctxAB (Fig. 5C), does not have all three tcpA mutations (no A266G), but does have three heptad repeats; Bgd3
contains only one copy of ctxAB (akin to wild-type El Tor
N16961 [Fig. 5B]) but all three tcpA mutations as well as three
heptad repeats; Bgd8 produced the second highest levels of CT
(Fig. 2), the highest levels of TcpA and ToxT (Fig. 3), carries
two copies of ctxAB (Fig. 5C), has only the C128T mutation in
tcpA, and has three heptad repeats; and BAA-2163, which was
the causative agent of the cholera outbreak in Haiti in 2010,
carries only one copy of the ctxAB operon (akin to wild-type El
Tor N16961 [Fig. 5B]), has all three tcpA mutations but also
carries an additional C58A mutation in ctxB and five heptad
repeats, neither of which have ever been observed in any previous strains.
As shown in Fig. 4A and B, El Tor variants Bgd8 and
MQ1795 demonstrated an increase in virulence at the inoculation dose tested compared to that of both wild-type El Tor
N16961 and C6706. The LT50 for El Tor variant MQ1795 was
22 h, 6 h sooner than that for wild-type N16961, whereas the
LT50 for variant Bgd8 was 25 h, 3 h sooner than that for
N16961. El Tor variants BAA-2163 (Fig. 4A), Bgd2, and Bgd3
(Fig. 4B) exhibited LT50s of 27, 26, and 29 h, respectively,
which is comparable to that of wild-type N16961. Wild-type

FIG. 3. Immunoblot assays and densitometry for V. cholerae virulence factors TcpA and ToxT. Whole-cell extracts (WCE) were prepared, and 8 and 10 g of total protein for TcpA and ToxT, respectively, was loaded onto a 16% Tris-glycine polyacrylamide gel. The
resulting band intensities were quantitated and normalized against
wild-type El Tor N16961. Anti-TcpA (A) or anti-ToxT (B) antibody
was used to probe for TcpA and ToxT, respectively, in wild-type
classical O395, wild-type El Tor C6706, wild-type El Tor N16961, and
El Tor variants Bgd1, Bgd2, Bgd3, Bgd4, Bgd5, Bgd6, Bgd7, Bgd8,
MQ1795, MQ04, and BAA-2163. O395⌬tcpA and O395⌬toxT are
shown as controls. Nonspecific bands serving as loading controls (LC)
are shown below each respective immunoblot.

C6706 demonstrated an LT50 of 43 h, much later than that of
N16961, whereas variant MQ04 did not kill any mice during
the course of the 48-h experiment (Fig. 4A).
Genetic analysis of variants reveals El Tor tcpA, with previously unreported mutations, classical ctxB genes, and duplication of the ctxAB operon on the small chromosome. Primers
listed in Table 3 were used to amplify and sequence the tcpA
and ctxB genes to determine whether these genes are of the
classical or El Tor biotype. PCR using primers for amplifying
tcpA yielded a product of 1,420 bp, while the ctxAB primers
yielded a 580-bp product. The sequencing of tcpA in the variants showed that the variants possessed El Tor versions of
tcpA, but it also revealed some point mutations compared to
the sequence of N16961. A cytosine-to-thymine point mutation
128 bp upstream of the ATG start site of tcpA was common to
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FIG. 4. Determining the relative virulence of the El Tor variant
strains using the infant mouse cholera model. The El Tor variant
strains were individually inoculated (infectious dose of ⬃7.5 ⫻ 108)
into infant mice (n ⫽ 6) to determine the length of time required
before half the population succumbs to infection (LT50) (inset). Wildtype El Tor C6706 and N16961 also were separately inoculated as
controls and to determine the relative virulence (hypo-, equi-, or hypervirulent) of the El Tor variant strains MQ1795, MQ04, and BAA2163 (A) and Bgd2, Bgd3, and Bgd8 (B).

the variants. An additional A266G point mutation, resulting in
a residue change of N89S, also was found in variants Bgd3,
Bgd4, Bgd5, Bgd6, MQ1795, MQ04, and BAA-2163. A third
mutation of an additional adenine base insertion 130 bp upstream of the ATG start site also was identified in all of the
variants tested except Bgd8. Although these mutations in tcpA
and the upstream region were the basis for representative
strain selection for the LT50 assay (Fig. 4), no correlation could
be made between these mutations and the amounts of TcpA
produced.
When the ctxB sequence was analyzed, all of the variants
tested were found to carry the classical version of ctxB, which
contains the residues H39 and T68, as opposed to Y39 and I68,
respectively, which were found in El Tor N16961 (Table 5).
Interestingly, the strain isolated from Haiti, BAA-2163, in addition to being of the classical biotype, also was found to have
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an additional mutation of a cytosine to an adenine at position
58, resulting in an H20N residue substitution, which is not
common to either classical O395 or El Tor N16961 (Table 5).
The downstream region of the CTX also was characterized
in the variants to determine if the chromosomal location(s) of
the phage is similar to that observed in wild-type El Tor (a
single copy on the large chromosome) or to wild-type classical
(two copies, one on each chromosome) (Fig. 5). Using downstream primers that were specific for either the large (ctxAB2Rev) or small (ctxAB1-Rev) chromosome and a common upstream primer (ctxB-For), it was determined that unlike the
wild-type N16961, variants Bgd2, Bgd7, Bgd8, MQ1795, and
MQ04 had the CTX inserted on both chromosomes (Fig.
5C), akin to classical O395, which has not been previously
reported for any El Tor variant strains. Although duplicated
CTX have been previously reported in some El Tor variants,
the reported duplications were tandem duplications of the
CTX on the large chromosome (14). In light of this report,
the tandem duplication of the CTX also was considered in
the El Tor variants of this study; however, analysis through
PCR revealed that this is not the case, and CTX duplication
is not found in tandem but individually on each chromosome.
Phylogenetic analysis groups the clinical El Tor variants
and the Haiti strain in the same clade as wild-type El Tor
N16961. The sequences of four genes (recA, pyrC, gyrB,
and groEL; classical accession numbers VC0395_A0070,
VC0395_0313, VC0395_A2504, and VC0395_A2237, respectively, and El Tor accession numbers VC0543, VCA0925,
VC0015, and VC2664, respectively) were analyzed in the clinical El Tor variant strains and were compared to wild-type
classical O395 and wild-type El Tor N16961 sequences to distinguish evolutionary lineages. The alignment of the sequences
and phylogenetic analysis revealed that the El Tor variants
belonged to the same phylogenetic clade as wild-type El Tor
N16961 (Fig. 6A), lending further support that the variants are
of an El Tor background. For comparison, the same genes in
the environmental V. cholerae strain 12129 also were analyzed
and incorporated into the phylogenetic analysis (Fig. 6A). As
expected, the environmental non-O1 V. cholerae strain 12129,
isolated from the Gulf Coast, was completely separate from
both classical and El Tor strains.
Phylogenetic analyses also were conducted that compared
ctxB (Fig. 6B) and tcpA (containing the upstream promoter
region) (Fig. 6C and D) of the variants to genes of the two
wild-type V. cholerae strains, N16961 and O395. As illustrated
in Fig. 6B, the ctxB gene clustered the variants with classical
O395, although the Haitian strain BAA-2163 grouped alone
within the same clade (Fig. 6B). In contrast, when analyzing
tcpA and the upstream promoter region, the variants grouped
with El Tor N16961 (Fig. 6C). Further dichotomy within this
clade was resolved in Fig. 6D, as variants Bgd1, Bgd2, Bgd7,
and Bgd8 grouped with wild-type N16961 and Bgd3, Bgd4,
Bgd5, Bgd6, MQ1795, MQ04, and BAA-2163 clustered together.
DISCUSSION
All of the clinical El Tor variant strains in this study display
differential cholera toxin and TcpA and ToxT expression profiles. The emergence of V. cholerae El Tor variants has not
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TABLE 5. Summary of genotypic traits of wild-type classical biotype strain O395, wild-type El Tor biotype strains
C6706 and N16961, and the El Tor variantsa
CTX location
Characteristic

Presence of
CTX

O395
C6706
N16961
Bgd1
Bgd2
Bgd3
Bgd4
Bgd5
Bgd6
Bgd7
Bgd8
MQ1795
MQ04
BAA-2163

Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes

Presence of tcpA variant with:

Large
chrom

Small
chrom

ctxB type

Presence of C58A
results in H20N
substitutions in
ctxB

Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes

Yes
No
No
No
Yes
No
No
No
No
Yes
Yes
Yes
Yes
No

Class
El Tor
El Tor
Class
Class
Class
Class
Class
Class
Class
Class
Class
Class
Class

No
No
No
No
No
No
No
No
No
No
No
No
No
Yes

tcpA type

Class
El Tor
El Tor
El Tor*
El Tor*
El Tor*
El Tor*
El Tor*
El Tor*
El Tor*
El Tor*
El Tor*
El Tor*
El Tor*

A266Gb
results in
N89S
substitution

Ac
insertion

C to Tb,d
substitution

NA
No
NA
No
No
Yes
Yes
Yes
Yes
No
No
Yes
Yes
Yes

NA
No
NA
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
Yes
Yes
Yes

NA
No
NA
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes

No. of
heptads

7
4
4
3
3
3
4
4
3
3
3
4
4
5

a

Chrom, chromosome; Class, classical biotype strain; El Tor, El Tor biotype strain; El Tor*, El Tor biotype variant strains (see the text); NA, not applicable.
The numbering refers to the sequence of wild-type El Tor N16961.
Insertion is 130 bp upstream of the translational start site.
d
Substitution is 128 bp upstream of the translational start site.
b
c

been limited to Bangladesh and Mozambique, it also has been
isolated and identified in parts of Asia (38, 45) and now in
Haiti (1, 6, 7, 8), with cases originating from Haiti being reported in different parts of the United States (9) and even
Canada. With the differences in the locations of where these
diverse variants are being isolated come the inherent differences in genotypic and phenotypic profiles, as previously described elsewhere (28, 29, 33, 39, 44, 45). An alarming concern
has been the growing number of unpublished reports and one
recently published report (16) revealing various amounts of
cholera toxin being produced by the different El Tor variants
isolated. Our initial clinical patient profiles (Table 1) revealed
that the patients all suffered from severe watery diarrhea, a
hallmark manifestation of cholera. With the previous knowledge of El Tor variants and anecdotal reports of various cholera toxin production levels at the time this investigation was
initiated, we proceeded to characterize the clinical El Tor
variants isolated from various patients in Bangladesh and the
representative strain from Haiti.
A recent report had determined that 19 different El Tor
variants isolated between 1996 and 2007 produced CT levels
equivalent to that of wild-type classical strains (16), which was
on the level of approximately 20-fold higher than that of wildtype El Tor strains. Similarly, the El Tor variants in this study
all demonstrated an increase in the amount of CT produced,
although the level of increased production varied among the
strains. Variants Bgd8 and MQ1795 produced 6- and 7-fold
larger amounts of CT, respectively, than both wild-type classical and El Tor strains (Fig. 2).
Our initial hypothesis was that the differing amounts of CT
produced by the variants (Fig. 2) would be directly linked to
the master virulence factor regulator, ToxT, and directly correlated to the differing amounts of other virulence factors
produced, primarily TcpA. We first examined the levels of
TcpA and ToxT produced by the 11 clinical El Tor variant

isolates, and we observed that under AKI-inducing conditions
(virulence gene expression-inducing conditions for El Tor biotypes), variants Bgd8 and MQ1795 produced much higher levels of both TcpA and ToxT (Fig. 3). However, the TcpA and
ToxT levels were not duplicated in the remaining variants, all
of which produced lower levels of TcpA and various higher
levels of ToxT than wild-type El Tor N16961. Since ToxT is the
master regulator (activator) for virulence gene expression, it
would make intuitive sense that higher levels of ToxT would in
turn activate higher levels of tcp gene expression, resulting in
increased amounts of TcpA being produced. We initially hypothesized that the higher level of TcpA observed in MQ1795
was the result of a mutation in the promoter region of tcpA
resulting in a tcpA promoter with a higher affinity for ToxT.
However, sequence analysis of the upstream region of tcpA
identified two point mutations in the ToxT binding region,
neither of which were unique to MQ1795. The different combinations of the three point mutations varied across the 11
variant strains and do not point to a common mutation that
could be attributed to any specific strain to account for the
observed phenotype of various ToxT and TcpA production
levels (Table 5).
Another explanation may reside with mutations in toxT that
may be attributable to the increased levels of ToxT production
in MQ1795; however, sequence analysis of toxT in all variants
studied revealed no alterations from the sequence of wild-type
N16961. Without further analysis of the entire genome through
such techniques as deep sequencing, it is very difficult to even
hypothesize what could account for the differences observed in
ToxT and TcpA expression levels across the variants, especially
since none of the mutations are unique to any one strain.
An alternative explanation for the increased CT production
observed resides with the copy number of the ctxAB operon.
This El Tor variant carries two copies of the ctxAB operon, one
on each of the large and small chromosomes, akin to classical
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FIG. 5. Comparative schematic illustrating the hypothesized arrangement of the CTX integration in some of the El Tor variants. The
orientation of the ctxAB operon in the large and small chromosomes of wild-type classical biotype O395 (A), wild-type El Tor biotype N16961 (B),
and some of the El Tor biotype variants (MQ1795, MQ04, Bgd2, Bgd7 and Bgd8) (C) are shown. The ctxB gene was amplified in the El Tor variants
by PCR using classical large and small chromosome-specific primers (primers 57 and 56, respectively). PCR and sequencing revealed that cxtB was
present on both the large and small chromosomes of the variants, and both copies were that of the classical ctxB sequence (red asterisk, H39 in
classical and El Tor variants and Y39 in El Tor N16961; blue asterisk, T68 in classical and El Tor variants and I68 in El Tor N16961). Relative
attL and attR sequences (attB in El Tor N16961 small chromosome) are shown as shaded boxes. Identical sequences across the strains are
color-coded and indicated with size (in bp). Positions of primers used for PCR and sequencing (primers 39, 51, 56, and 57) all are indicated with
directional green arrows.

biotype strains. Unlike the wild-type El Tor biotype N16961,
which only has a single copy of the operon on the large chromosome, this duplication of the ctxAB operon may account for
the observed increase in the CT produced even though ToxT
levels do not vary, much like the difference observed between
low- and high-copy expression plasmids.
To further investigate this possibility, sequence analysis
was performed on all of the El Tor variants in this study
through chromosome-specific PCR. El Tor variant strains
Bgd2, Bgd7, Bgd8, MQ1795, and MQ04 have a duplicated
ctxAB operon, one copy residing on each chromosome. PCR
with a forward ctxB primer (primer 51; Table 3) and either
a small or large chromosome-specific primer (primer 56 or
57, respectively; Table 3) generated chromosome-specific
products, much like wild-type classical O395. Neither wildtype El Tor C6706 nor N16961 produced a PCR product
when using the small chromosome-specific primer (data not
shown). However, as increased levels of CT also were observed in the variants that have only a single copy of the

ctxAB operon (i.e., Bgd1, Bgd3, Bgd4, Bgd5, Bgd6, and
BAA-2163), the duplication of the ctxAB operon cannot be
the only explanation. Furthermore, as there is no consistency between the differences in phenotypes (Table 4) and
the genotypes (Table 5) of these variants, the observations
made most likely are due to the result of alternative mechanisms. It is plausible that this mechanism could be identified by looking at the genome sequence of the variants and
identifying mutations in the DNA sequences, particularly of
regulatory proteins or promoter regions. These data suggest
a higher level of complexity in the regulatory cascade than
originally predicted.
El Tor variants Bgd8 and MQ1795 are hypervirulent in the
infant mouse cholera model. The inoculation of infant mice
has been used previously to determine V. cholerae strain virulence (23) by interpolating the length of time required for half
the inoculated population to succumb to the infection (LT50).
Using the infant mouse cholera model, the representative clinical El Tor variants were individually inoculated (⬃7.5 ⫻ 108
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FIG. 6. Phylogenetic analysis of the El Tor variants. (A) The four
genes recA, pyrC, gyrB, and groEL were used to determine the phylogenetic relatedness of the El Tor variants MQ1795, MQ04, Bgd1,
Bgd2, Bgd3, Bgd4, Bgd5, Bgd6, Bgd7, Bgd8, and BAA-2163 to wildtype El Tor biotype strain N16961 and classical biotype strain O395.
The environmental strain, 12129, also was included in panel A for
comparative purposes. Phylogenetic relatedness of the variants was
compared to both O1 classical and El Tor wild-type strains with respect
to ctxB (B) and tcpA (C and D) with the promoter region. (D) The
clades generated in the tcpA branch showing the divergence of the
variants and wild-type N16961 were further resolved. The bootstrap
number at the node indicates the confidence for the clade grouping as
determined by MEGA5 software. The scale bar represents the branch
distance between the different strains.
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bacteria) alongside both wild-type El Tor strains, and the mice
were observed for a period of 48 h.
With the characteristics of MQ1795 demonstrated in the CT
assay and Western blot analysis, our prediction of MQ1795
being more virulent than both wild-type El Tor strains was
validated. The LT50 of MQ1795 was determined to be 22 h
postinoculation, which was 6 h faster than that of wild-type
N16961. This result was not surprising, as a strain that produces greater levels of the master virulence gene regulator,
ToxT, and therefore more TcpA and cholera toxin, would be
more virulent. Increased levels of TcpA would allow the bacterium to better establish itself in the intestinal tract, while
increased levels of CT would give rise to a substantially increased lethal effect. These results, when considered with the
virulence factor expression profile described above and this
variant’s lack of detectable biofilm production (Table 4),
strongly suggests that this particular El Tor variant has been
well adapted to be the most fit in the host rather than in the
environment, where the ability to produce a good biofilm
would be more favorable.
Variant Bgd8, which produced the second highest levels of
CT but the highest levels of both TcpA and ToxT, also proved
to be more virulent in the infant mouse cholera model than
wild-type El Tor strains N16961 and C6706. Akin to MQ1795,
a similar increase in virulence in Bgd8 can be attributed to the
increased levels of the master regulator ToxT and its effects on
the virulence genes downstream.
Variants Bgd2, Bgd3, and BAA-2163, although genetically
different from each other in terms of both ctxAB operon number and tcpA sequence (Table 5), did not exhibit any noticeable
differences in virulence compared to that of wild-type N16961,
despite producing greater levels of CT (Fig. 2). It appears that
the copy number of the ctxAB operon alone does not give rise
to increased levels of CT. Bgd2 contains two copies of the
ctxAB operon, whereas Bgd3 and BAA-2163 only carry one
copy (Table 5). However, Bgd2 and Bgd3 produced relatively
equal levels of CT (Fig. 2), and BAA-2163 produced half that
of either Bgd2 or Bgd3. All three of these variants differ in
their ctxB sequence and tcpA mutations yet produce no significant differences in CT, TcpA, or ToxT production levels, and
they are relatively as virulent as wild-type N16961.
Variant MQ04 produced wild-type levels of TcpA but produced elevated levels of ToxT and CT, suggesting that this
strain has the potential to be hypervirulent, much like variant
MQ1795. However, in the infant mouse cholera model this
variant proved to be avirulent at an infectious dose of ⬃7.5 ⫻
108 bacteria, as none of the inoculated mice died within the
48-h incubation period. In lieu of the levels of ToxT, TcpA, and
CT produced, it is unusual that this variant did not kill any of
the hosts. However, further analysis revealed that this strain is
unable to effectively colonize the intestines of the infant mouse
cholera model (the competitive index was decreased by 2 log
[data not shown]), although wild-type levels of TcpA are produced. Interestingly, variant MQ04 produced the most biofilm
out of the three variants studied. This observation, in conjunction with the lack of virulence, suggests a different evolutionary
path for this variant compared to that for variant MQ1795.
Contrary to the hypervirulent MQ1795, which did not produce
detectable levels of biofilm, variant MQ04 displays phenotypic
traits that suggest that this variant is more fit for survival in an
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environment where the ability to produce a biofilm is more
advantageous rather than inside a host.
The results of our genotypic and phenotypic analyses of the
11 El Tor variants and those of the wild-type El Tor C6706 and
N16961 are summarized in Tables 4 and 5. The phenotypic
assays confirmed that all variants in this study are of the El Tor
biotype background. Of interest were the results of the VogesProskauer (VP) test that is used to distinguish between classical and El Tor biotypes (36). Classical biotype strain O395 is
VP negative, as it does not produce the intense bright pink
coloration observed in the El Tor biotype strains C6706 and
N16961 (Fig. 1). Although all variants in this study are of the
El Tor background, the results of the VP test were not as
clear-cut as those observed in the wild-type classical and El Tor
strains. The VP test on the clinical isolates resulted in negative
(no coloration in MQ1795) or weakly positive (slightly pink
coloration in the remaining 10 isolates) results, while the El
Tor wild-type strains were positive (Fig. 1). It is obvious that
the metabolic capabilities of these variants have been altered
over the course of their independent evolutions, and it is not
unreasonable to believe that environmental pressures have
inadvertently or purposefully favored mutations in these
strains. Further investigation into the metabolic characteristics
of these strains would identify these and any other metabolic
differences.
Genetic analysis of the tcpA gene also is routinely conducted
to verify the biotype background of V. cholerae isolates (4, 11,
34, 45) and was used in this study. The tcpA gene in all clinical
variants in this study was sequenced and confirmed to be of the
El Tor biotype, with three mutations (Table 5). Among these
mutations was a base change that was conserved across all El
Tor variants of a cytosine to a thymine 128 bp upstream of the
tcpA ATG start site. A missense mutation of an A266G in the
coding region, resulting in an amino acid change from asparagine to serine (N89S), was found in Bgd3, Bgd4, Bgd5, Bgd6,
MQ1795, MQ04, and BAA-2163. The third mutation was an
insertion of an extra adenine in the stretch of adenines approximately 130 bp upstream of the ATG start site of tcpA. This
mutation was found in all of the variants except Bgd8. As
previously mentioned, the consequences of these mutations or
combination of mutations have not yet been elucidated and are
under investigation. However, the mutations do not seem to
have a direct influence over tcpA expression or virulence, as no
direct correlation could be made and no unifying theme could
be identified.
To determine the phylogenetic similarity between the El Tor
variants and the wild-type classical and El Tor biotype strains,
sequence analyses of several genes (recA, pyrC, gyrB, and
groEL) were used. Although all previous assays strongly suggested the variants are of El Tor lineage, a comparison of these
genes lends more evidence that these variants are of the El Tor
background. The strong evolutionary lineage to the El Tor
wild-type N16961 strain, as evidenced by inclusion in the same
phylogenetic clade, further illustrates the observations of classical strain displacement by El Tor strains. These sequence and
phylogenetic analyses also have revealed that the El Tor variants can be further subdivided based on tcpA and its upstream
promoter region, which raises interesting questions regarding
the evolution of the variants within a smaller geographic location. The inclusion of BAA-2163 as an El Tor variant is not
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surprising, as its origin has been one of the central foci to
emerge from the Haitian outbreak. However, the sequence of
the ctxB locus in BAA-2163 has identified a unique mutation
never observed in any other El Tor variants, C58A (Table 5).
This single mutation could call into question not only the true
origin of this variant but also the evolutionary timeline that this
particular strain has followed. Another intriguing observation
was the identification of an unusual number of heptad repeats
(TTTTGAT) found in the promoter region of the ctxAB
operon. Where classical O395 has seven heptad repeats and El
Tor has four, the 10 Bangladesh El Tor variants have either
three or four. However, the Haitian strain BAA-2163 was
found to have five heptad repeats in the promoter region of the
ctxAB operon, which has never been reported in any other
strain. This particular feature, in conjunction with the unique
mutation found within the ctxB locus, suggests an alternative
origin or lineage (Fig. 6B).
The emergence and prevalence of V. cholerae El Tor variants
has been reported in several geographic regions (1, 6, 12, 13,
33, 38, 45), and their independent evolution has led to various
combinations of classical traits possessed by the different variant strains identified. Even in the 11 clinical El Tor variants
isolated from the same hospital and from Haiti presented here,
there exists significant variation among them, with regard not
only to virulence gene expression but also to other phenotypic
properties, such as alteration in basic metabolic pathways, biofilm production, and differing hemolytic activities. These differences, especially the potential of duplicated or deleted sequences, such as that of the CTX genome, warrants further
investigation. Alternative approaches, such as deep sequencing
and de novo genome synthesis, may reveal more information
that can help elucidate the differences observed and differences yet to be observed.
ACKNOWLEDGMENTS
This work was supported by NIAID grants AI025096 and AI039654.
REFERENCES
1. Ali, A., et al. 2011. Recent clonal origin of cholera in Haiti. Emerg. Infect.
Dis. 17:699–701.
2. Almagro-Moreno, S., and E. F. Boyd. 2009. Insights into the evolution of
sialic acid catabolism among bacteria. BMC Evol. Biol. 9:118–133.
3. Ansaruzzaman, M., et al. 2004. Cholera in Mozambique, variant of Vibrio
cholerae. Emerg. Infect. Dis. 10:2057–2059.
4. Ansaruzzaman, M., et al. 2007. Genetic diversity of El Tor strains of Vibrio
cholerae O1 with hybrid traits isolated from Bangladesh and Mozambique.
Int. J. Med. Microbiol. 297:443–449.
5. Barua, D. 1992. History of cholera, p. 1–36. In D. Barua and W. B. Greenough III (ed.), Cholera. Plenum Publishing Corporation, New York, NY.
6. Ceccarelli, D., et al. 2011. Origin of Vibrio cholerae in Haiti. Lancet Infect.
Dis. 11:262.
7. Centers for Disease Control and Prevention. 2010. Cholera outbreak–Haiti,
October 2010. MMWR Morb. Mortal. Wkly. Rep. 59:1411.
8. Centers for Disease Control and Prevention. 2010. Update: outbreak of
cholera–Haiti, 2010. MMWR Morb. Mortal. Wkly. Rep. 59:1586–1590.
9. Centers for Disease Control and Prevention. 2010. Update on cholera–Haiti,
Dominican Republic, and Florida, 2010. MMWR Morb. Mortal. Wkly. Rep.
59:1637–1641.
10. Champion, G. A., et al. 1997. A branch in the ToxR regulatory cascade of
Vibrio cholerae revealed by characterization of toxT mutant strains. Mol.
Microbiol. 23:323–331.
11. Chatterjee, S., et al. 2009. Vibrio cholerae O1 clinical strains isolated in 1992
in Kolkata with progenitor traits of the 2004 Mozambique variant. J. Med.
Microbiol. 58:239–247.
12. Chin, C., et al. 2011. The origin of the Haitian cholera outbreak strain.
N. Engl. J. Med. 364:33–42.
13. de Lorenzo, V., and K. Timmins. 1994. Analysis and construction of stable
phenotypes in gram-negative bacteria with Tn5- and Tn10-derived minitransposons. Methods Enzymol. 235:386–405.

VOL. 49, 2011

CHARACTERIZATION OF CLINICAL EL TOR VARIANT ISOLATES

14. Faruque, S. V., et al. 2007. Genomic analysis of the Mozambique strain of
Vibrio cholerae O1 reveals the origin of El Tor strains carrying classical CTX
prophage. Proc. Natl. Acad. Sci. U. S. A. 104:5151–5156.
15. Gardel, C., and J. Mekalanos. 1994. Regulation of cholera toxin by temperature, pH and osmolarity. Methods Enzymol. 235:517–526.
16. Ghosh-Banerjee, J., et al. 2010. Cholera toxin production by the El Tor
variant of Vibrio cholerae O1 compared to prototype El Tor and classical
biotypes. J. Clin. Microbiol. 48:4283–4286.
17. Herrington, D., et al. 1988. Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans. J. Exp. Med.
168:1487–1492.
18. Iwanaga, M., et al. 1986. Culture conditions for stimulating cholera toxin
production by Vibrio cholerae O1 El Tor. Microbiol. Immunol. 30:1075–1083.
19. Kaper, J., et al. 1995. Cholera. Clin. Microbiol. Rev. 8:48–86.
20. Kaper, J. B., et al. 1982. Molecular epidemiology of Vibrio cholerae in the
U.S. Gulf Coast. J. Clin. Microbiol. 16:129–134.
21. Karaolis, D. K., et al. 1998. A Vibrio cholerae pathogenicity island associated
with epidemic and pandemic strains. Proc. Natl. Acad. Sci. U. S. A. 95:3134–
3139.
22. Karaolis, D. K., et al. 1995. The sixth and seventh cholera pandemics are due
to independent clones separately derived from environmental, nontoxigenic,
non-O1 Vibrio cholerae. J. Bacteriol. 177:3191–3198.
23. Kirn, T., et al. 2003. Secretion of a soluble colonization factor by the TCP
type 4 pilus biogenesis pathway in Vibrio cholerae. Mol. Microbiol. 49:81–92.
24. Kirn, T. J., et al. 2000. Delineation of pilin domains required for bacterial
association into microcolonies and intestinal colonization by Vibrio cholerae.
Mol. Microbiol. 35:896–910.
25. Kovacikova, G., et al. 2005. Dual regulation of genes involved in acetoin
biosynthesis and motility/biofilm formation by the virulence activator AphA
and the acetate-responsive LysR-type regulator AlsR in Vibrio cholerae. Mol.
Microbiol. 57:420–433.
26. Kovacikova, G., and K. Skorupski. 1999. A Vibrio cholerae LysR homolog,
AphB, cooperates with AphA at the tcpPH promoter to activate expression
of the ToxR virulence cascade. J. Bacteriol. 181:4250–4256.
27. Kovacikova, G., and K. Skorupski. 2001. Overlapping binding sites for the
virulence gene regulators AphA, AphB and cAMP-CRP at the Vibrio cholerae tcpPH promoter. Mol. Microbiol. 41:393–407.
28. Lan, R., and P. Reeves. 2002. Pandemic spread of cholera: genetic diversity
and relationships within the seventh pandemic clone of Vibrio cholerae determined by amplified fragment length polymorphism. J. Clin. Microbiol.
40:172–181.
29. Lee, J., et al. 2006. Multilocus sequence typing (MLST) analysis of Vibrio
cholerae O1 El Tor isolates from Mozambique that harbour the classical
CTX prophage. J. Med. Microbiol. 55:165–170.
30. Li, C. C., et al. 2000. Molecular cloning and transcriptional regulation of
ompT, a ToxR-repressed gene in Vibrio cholerae. Mol. Microbiol. 35:189–
203.
31. Miller, V. L., et al. 1987. Cholera toxin transcriptional activator toxR is a
transmembrane DNA binding protein. Cell 48:271–279.
32. Morales, R., G. Delgado, and A. Cravioto. 2008. Population genetics of Vibrio

33.

34.

35.

36.

37.
38.

39.

40.

41.
42.
43.

44.
45.
46.

47.

48.
49.
50.

3749

cholerae, p. 29–47. In S. M. Faruque and G. B. Nair (ed.), Vibrio cholerae–
genomics and molecular biology. Caister Academic Press, Norfolk, Untied
Kingdom.
Morita, M., et al. 2008. Development and validation of a mismatch amplification mutation PCR assay to monitor the dissemination of an emerging
variant of Vibrio cholerae O1 biotype El Tor. Microbiol. Immunol. 52:314–
317.
Nair, G., et al. 2002. New variants of Vibrio cholerae O1 biotype El Tor with
attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh. J. Clin. Microbiol. 40:3296–3299.
Nair, G., et al. 2006. Isolation of Vibrio cholerae O1 strains similar to preseventh pandemic El Tor strains during an outbreak of gastrointestinal
disease in an island resort in Fiji. J. Med. Microbiol. 55:1559–1562.
Nair, G. B., et al. 2008. Emerging hybrid variants of Vibrio cholerae O1, p.
179–190. In S. M. Faruque and G. B. Nair (ed.), Vibrio cholerae–genomics
and molecular biology. Caister Academic Press, Norfolk, United Kingdom.
Nair, G. B., et al. 2006. Cholera due to altered El Tor strains of Vibrio
cholerae O1 in Bangladesh. J. Clin. Microbiol. 44:4211–4213.
Nguyen, B., et al. 2009. Cholera outbreaks caused by an altered Vibrio
cholerae O1 El Tor biotype strain producing classical cholera toxin B in
Vietnam in 2007 to 2008. J. Clin. Microbiol. 47:1568–1571.
Nusrin, S., et al. 2004. Diverse CTX phages among toxigenic Vibrio cholerae
O1 and O139 strains isolated between 1994 and 2002 in an area where
cholera is endemic in Bangladesh. J. Clin. Microbiol. 42:5854–5856.
O’Toole, G. A., and R. Kolter. 1998. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling
pathways: a genetic analysis. Mol. Microbiol. 28:449–461.
Pfau, J. D., and R. K. Taylor. 1996. Genetic footprint on the ToxR-binding
site in the promoter for cholera toxin. Mol. Microbiol. 20:213–222.
Sack, D., et al. 2004. Cholera. Lancet 363:223–233.
Safa, A., et al. 2006. Genetic characteristics of Matlab variants of Vibrio
cholerae O1 that are hybrids between classical and El Tor biotypes. J. Med.
Microbiol. 55:1563–1569.
Safa, A., et al. 2010. Evolution of new variants of Vibrio cholerae O1. Trends
Microbiol. 18:46–54.
Safa, A., et al. 2008. Vibrio cholerae O1 hybrid El Tor strains, Asia and
Africa. Emerg. Infect. Dis. 14:987–988.
Tamura, K., et al. MEGA5: molecular evolutionary genetics analysis using
maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. doi:10.1093/molbev/msr121.
Taylor, R. K., et al. 1987. Use of phoA gene fusions to identify a pilus
colonization factor coordinately regulated with cholera toxin. Proc. Natl.
Acad. Sci. U. S. A. 84:2833–2837.
Vogel, H., and D. Bonner. 1956. Acetylornithinase of Escherichia coli: partial
purification and some properties. J. Biol. Chem. 218:97–106.
Waldor, M. K., and J. J. Mekalanos. 1996. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 272:1910–1914.
Yu, R. R., and V. J. DiRita. 2002. Regulation of gene expression in Vibrio
cholerae by ToxT involves both antirepression and RNA polymerase stimulation. Mol. Microbiol. 43:119–134.

